Status:
COMPLETED
Efficacy and Safety Study of an Oral Contraceptive in Healthy Females
Lead Sponsor:
Bayer
Conditions:
Contraception
Eligibility:
FEMALE
18-35 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether the study drug is safe and effective in the prevention of pregnancies in a large group of volunteers.
Detailed Description
This study has previously been posted by Berlex, Inc. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals Inc.. Bayer HealthCare Pharmaceuticals Inc. is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Healthy women between the ages of 18 and 35 years requiring contraception
Exclusion
- Pregnancy, lactation, and contraindication of combined oral contraceptive
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
499 Patients enrolled
Trial Details
Trial ID
NCT00206583
Start Date
March 1 2005
End Date
July 1 2007
Last Update
October 1 2014
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
Women and Children's Hospital, Los Angeles
Los Angeles, California, United States, 90033
2
Lifespan Research
Palo Alto, California, United States, 94301
3
Genesis Center for Clinical Research
San Diego, California, United States, 92103
4
Medical Center for Clinical Research
San Diego, California, United States, 92108